oncology penny stocks

  • Biotech Weekly: Lung Cancer Data, Emerging Stock Drug Launch, Stroke Trial

    Biotech Weekly: Lung Cancer Data, Emerging Stock Drug Launch, Stroke Trial

    Three biotech stories this week that most people missed. A clinical-stage oncology company posted Phase 2 lung cancer data that sent its stock up 16% and earned an ASCO podium. A under-the-radar stock with a real FDA-approved product secured national pharmacy coverage and launched a real-world evidence study. And a micro-cap developing a stroke drug…

    read more